Pharma & Biotech

Shares of Gilead Sciences are consolidating near the $120 level following significant clinical and financial developments. The company announced that...

While Clover Health Investments, Corp. (NASDAQ: CLOV) shares continue to face downward pressure, a newly scheduled event has given market...

Shares of Viking Therapeutics are currently trading within a narrow band between $35 and $36, continuing a period of consolidation...

The investment case for pharmaceutical giant Novo Nordisk is encountering significant pressure. A combination of revised analyst outlooks, emerging legal...

Shares of clinical-stage biopharmaceutical company Ocugen saw elevated trading activity on Monday, with volume running 72% above the average. This...

A significant disconnect has emerged between Healwell AI Inc.'s operational results and its stock market valuation. Despite posting record-breaking quarterly...

Ocugen's stock closed at $1.38 on Friday, marking a single-day gain of 5.34%. This advance represents the third consecutive trading...

The biotechnology firm Ocugen enters the new trading week with positive momentum. Following a multi-day advance, investors are assessing whether...

A California jury has delivered a significant legal blow to Johnson & Johnson, ordering the healthcare giant to pay $40...

After a period of significant volatility, shares of X4 Pharmaceuticals may be entering a phase of consolidation. The stock closed...